Tags

Type your tag names separated by a space and hit enter

Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia.
Haematologica. 2018 07; 103(7):e307-e310.H

Authors+Show Affiliations

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA jorgej_castillo@dfci.harvard.edu. Harvard Medical School, Boston, MA, USA.Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, MA, USA.

Pub Type(s)

Letter

Language

eng

PubMed ID

29472352

Citation

Castillo, Jorge J., et al. "Ibrutinib Withdrawal Symptoms in Patients With Waldenström Macroglobulinemia." Haematologica, vol. 103, no. 7, 2018, pp. e307-e310.
Castillo JJ, Gustine JN, Meid K, et al. Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia. Haematologica. 2018;103(7):e307-e310.
Castillo, J. J., Gustine, J. N., Meid, K., Dubeau, T., Severns, P., & Treon, S. P. (2018). Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia. Haematologica, 103(7), e307-e310. https://doi.org/10.3324/haematol.2017.186908
Castillo JJ, et al. Ibrutinib Withdrawal Symptoms in Patients With Waldenström Macroglobulinemia. Haematologica. 2018;103(7):e307-e310. PubMed PMID: 29472352.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia. AU - Castillo,Jorge J, AU - Gustine,Joshua N, AU - Meid,Kirsten, AU - Dubeau,Toni, AU - Severns,Patricia, AU - Treon,Steven P, Y1 - 2018/02/22/ PY - 2018/2/24/pubmed PY - 2019/8/2/medline PY - 2018/2/24/entrez SP - e307 EP - e310 JF - Haematologica JO - Haematologica VL - 103 IS - 7 SN - 1592-8721 UR - https://www.unboundmedicine.com/medline/citation/29472352/Ibrutinib_withdrawal_symptoms_in_patients_with_Waldenström_macroglobulinemia_ L2 - http://www.haematologica.org/cgi/pmidlookup?view=long&pmid=29472352 DB - PRIME DP - Unbound Medicine ER -